arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

LIGAND PHARMACEUTICALS INC

LGND

$298.24 ▼ -0.63 (-0.21%) at close

19 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

LIGAND PHARMACEUTICALS INC shows strong fundamentals with top-quartile Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.8B

Dividend Yield —

Revenue Growth 60.4% ↗

Op. Margin 15.3% ↗

ROIC 3.2% ↘

FCF / Share $2.53 ↘

Trailing P/E 46.3x

Price / Book 5.8x

FCF Yield 0.9%

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

19-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$268.09M

↑ +60.4% —

Net Income Profit after all expenses

$124.45M

↑ +3186.6% —

Operating Margin Operating profit as % of sales

15.3%

↑ +213.1% 67th

FCF / Share Free cash flow per share

$2.53

↓ -51.4% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↓

Returns ↑

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue Growth YoY (%)	60.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+655%)	27.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+241%)	-33.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-514%)	-18.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-334%)	29.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+270%)	55.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+587%)	-52.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-752%)	78.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+878%)	29.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+269%)	51.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+544%)	11.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+43%)	31.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+297%)	56.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+600%)	4.5% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-44%)	27.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+245%)	-39.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-594%)	—	—	—
EPS Growth YoY (%)	N/M	N/M	N/M	N/M	N/M	N/M	389.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	1028.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	1867.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	5.4% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	N/M	N/M	N/M	N/M	339.1% Excellent Excellent Year-over-year change in net income	1041.5% Excellent Excellent Year-over-year change in net income	N/M	N/M	1811.4% Excellent Excellent Year-over-year change in net income	5.3% Fair Fair Year-over-year change in net income	N/M	N/M	N/M	-432.5% Weak Weak Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	-51.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	95.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-62.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	68.8% Excellent Excellent Year-over-year change in free cash flow	36.0% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	122.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	40.0% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	39.5% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	108.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	0.7% Caution ↓ Caution Declining Year-over-year change in free cash flow	N/M	65.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	95.4% Excellent Excellent Year-over-year change in free cash flow	24.0% Good Good Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	11.0% Good ↑ Good Improving Compound annual revenue growth over 3 years	-11.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-11.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	17.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-1.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	9.7% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	3.3% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	51.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	29.8% Excellent → Excellent Stable Compound annual revenue growth over 3 years	30.6% Excellent → Excellent Stable Compound annual revenue growth over 3 years	31.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	29.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	27.7% Excellent Excellent Compound annual revenue growth over 3 years	-6.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	7.5% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	6.8% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-12.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	6.8% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	17.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	21.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	13.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	38.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	35.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	29.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	25.0% Excellent Excellent Compound annual revenue growth over 5 years	10.6% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	-20.2% Weak Weak Compound annual EPS growth over 3 years	—	—	-16.5% Weak Weak Compound annual EPS growth over 3 years	0.6% Caution Caution Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Operating Margin (%) (%)	15.3% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-13.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-190%)	9.1% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-39%)	1.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-90%)	43.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+187%)	13.9% Fair ↓ Fair Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-8%)	—	65.1% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+334%)	48.2% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+222%)	40.3% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+168%)	38.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+153%)	30.4% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+103%)	30.5% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+103%)	0.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-96%)	-2.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-115%)	-124.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-930%)	-25.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-271%)	—	—
Effective Tax Rate (%) (%)	21.7% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	260.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.5% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	114.5% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	71.7% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	46.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+287%)	-2.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-120%)	39.7% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+231%)	-17.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-242%)	23.7% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+97%)	-1.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-113%)	—	57.0% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+375%)	8.9% Caution → Caution Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-26%)	-1.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-113%)	—	18.6% Good → Good Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+55%)	23.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+94%)	-1.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-114%)	32.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+170%)	-44.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-467%)	-5.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-142%)	—	—
FCF Margin (%) (%)	18.2% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	57.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	35.1% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	61.1% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	29.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	26.9% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	-26.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	76.8% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	61.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	56.1% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	57.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	31.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	41.5% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-4.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-115.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-88.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.39x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-23.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-3.59x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-16.79x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.35x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	6.88x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-37.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.71x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.78x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	-0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.62x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	17.62x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Return on Invested Capital (%)	3.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	4.4% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	1.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	1.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	83.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	23.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	13.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	10.2% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	9.1% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	58.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	23.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	0.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	477.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-210.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	2.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	8.0% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	1.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	54.0% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	13.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	10.1% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	7.3% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	5.4% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	7.6% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	14.3% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-38.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	12.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	-0.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-103%)	7.4% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-50%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	7.0% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-54%)	-0.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-103%)	82.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+447%)	25.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+70%)	3.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-79%)	-0.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-103%)	96.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+546%)	45.7% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+205%)	23.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+53%)	-2.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	118.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+691%)	213.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1326%)	-52.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-447%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Interest Coverage (x)	127.73x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-85.95x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	18.20x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	1.69x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	5.29x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	0.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	22.58x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	3.39x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	5.06x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	3.60x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	2.32x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	4.04x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	7.19x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	0.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-505.24x Weak Weak Operating income divided by interest expense Optimal: > 5x	-36.91x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-174.93M	$-72.31M	$-22.95M	$-45.01M	$-19.52M	$-47.62M	$-71.54M	$-117.16M	$-20.62M	$-18.75M	$-97.43M	$-160.20M	$-11.64M	$-12.38M	$-7.04M	$-3.35M	$-16.03M	$-28.75M	—

📊 What does each share earn? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue per Share (USD)	$13.86	$9.14	$7.59	$11.63	$14.52	$11.52	$6.33	$11.88	$6.71	$5.23	$3.63	$3.16	$2.41	$1.58	$1.53	$1.20	$2.06	—	—
Basic EPS, GAAP (USD)	$6.44	$-0.22	$3.02	$-1.98	$3.44	$-0.18	$33.13	$6.77	$0.60	$-0.08	$11.61	$0.59	$0.56	$-0.03	—	—	—	—	—
Free Cash Flow per Share (USD)	$2.53	$5.21	$2.66	$7.11	$4.21	$3.10	$-1.68	$9.13	$4.11	$2.94	$2.10	$1.01	$1.00	$-0.02	$-0.06	$-1.38	$-1.82	—	—
Dividend per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$2.50
Book Value per Share (USD)	$51.44	$43.46	$39.92	$35.25	$48.97	$44.12	$45.61	$27.01	$18.90	$16.32	$11.89	$1.34	$2.42	$1.24	$0.40	$-0.25	$0.20	—	—
Tangible Book Value per Share (USD)	$34.91	$24.00	$16.97	$8.81	$20.21	$-4.69	$27.44	$12.25	$4.03	$3.08	$8.86	$-1.87	$-0.77	$-1.96	$-3.02	$-0.91	$0.20	—	—
Basic Weighted Avg Shares (shares)	19.34M	18.29M	17.30M	16.87M	16.63M	16.18M	19.00M	21.16M	21.03M	20.83M	19.79M	20.42M	20.31M	19.85M	19.66M	19.61M	18.86M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Working Capital (USD)	$794.82M	$294.45M	$220.65M	$164.79M	$423.09M	$400.45M	$1.11B	$788.29M	$-1.85M	$-64.08M	$-8.11M	$162.38M	$-4.06M	$-11.62M	$-11.41M	$3.53M	—	—	—
Total Equity (USD)	$1.02B	$830.44M	$700.91M	$597.49M	$821.16M	$709.52M	$767.23M	$560.91M	$399.79M	$341.29M	$237.28M	$26.32M	$49.61M	$26.48M	$8.19M	$-4.85M	$3.74M	$-10.37M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	$268.09M	$167.13M	$131.31M	$196.25M	$241.54M	$186.42M	$120.28M	$251.45M	$141.10M	$108.97M	$71.91M	$64.54M	$48.97M	$31.39M	$30.04M	$23.54M	$38.94M	—	—
Depreciation Expense (USD)	$33.77M	$35.24M	$36.52M	$51.53M	$51.07M	$25.69M	$18.36M	$12.78M	$11.71M	$11.29M	$2.63M	$2.66M	$2.66M	$2.73M	$2.79M	$2.21M	$4.63M	—	—
Net Income, GAAP (USD)	$124.45M	$-4.03M	$52.15M	$-33.36M	$57.14M	$-2.98M	$629.30M	$143.32M	$12.56M	$-1.64M	$229.82M	$12.02M	$11.42M	$-527.00K	$9.71M	$-10.37M	$-1.95M	—	—
Operating Cash Flow (USD)	$49.36M	$97.05M	$49.58M	$137.85M	$78.80M	$54.59M	$-29.34M	$194.06M	$88.57M	$63.00M	$41.73M	$20.57M	$20.69M	$161.00K	$-1.17M	$-27.07M	$-33.80M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 68 quarters

LIGAND PHARMACEUTICALS INC

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare LGND with peers